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SUMMARY 
In a double-blind study the advantages of a once-a-day dosage of a tricyclic antidepressant as against 
a thrice daily dosage regimen was evaluated using dothiepin (Prothiaden) and matching placebo tablets. 
Twenty eight adult patients of both sexes participated in the study and were randomly allocated to drug treat-
ment. Out of 28 patients who received dothiepin, 17 showed good improvement, in 6 improvement was 
fair and in 5 there was no improvement. These findings show that the response to dotheipin was satisfactory. 
Further, both treatments were equally effective in relieving symptoms of depression. 
Dothiepin hydrochloride (Prothiaden) 
is a tricyclic an ti-depressant. Chemically, 
it is ll-(3-dimethylaminopropylidene)-
6, 11 -dihydrodibenz (b, e) thiepin hydro-
chloride. Dothiepin possesses pharma-
cological properties similar to imipramine, 
amitriptyline and related drugs (Lipsedgi 
et al., 1971 ; Sim et al., 1975 ; Herridge, 
1975). 
Recently it has been reported by some 
workers that steady state plasma levels of 
a tricyclic antidepressant can be main-
tained by administering the drug as a 
single dose at night (Kramer, 1962 ; 
Dimascio and Shader, 1969 ; Marshall, 
1971) and clinical experience suggests that 
this method of administration is effective 
in relieving symptoms of depression. 
Dothiepin has a relatively long half-life 
which makes it suitable for a single dose 
administration (Horesovsky et al., 1967). 
"'Therefore, the present study was planned 
to assess the antidepressant properties of 
dothiepin and also to compare the efficacy 
and tolerability of two dosage regimens, 
viz. three times daily dose and single 
nocturnal dose of dothiepin in patients 
with depression. 
METHODOLOGY 
The study was conducted at the Depart-
ment of Psychiatry, Goa Medical College, 
Panaji, Goa. In this double-blind trial, 
30 patients suffering from depression as a 
primary illness and not a secondary mani-
festation of any other illness, and in whom 
treatment with antidepressants was thought 
suitable, were selected. All patietns were 
admitted initially for two weeks as in-
patients. The duration of the trial was 
four weeks. 
The patients admitted into the trial 
were randomly allocated to either Group 
D (three times daily dose) or Group N 
(single nocturnal dose). The group re-
ceiving three times daily dose of dothiepin 
was given equal total number of placebo 
tablets as a single dose at night and the 
group receiving single dose of dotheipin 
at night received identical placebo tablets 
three times daily in order to ensure that 
the trial remained strictly double-blind. 
Initially, in the first week, patients 
belonging to group D received one tablet 
of dothiepin three times daily and patients 
in group N were given single nocturnal 
dose of three dothiepin tablets. Thereafter, 
depending on the patient's response, dose 
was increased every week, the maximum 
number of dothiepin tablets being six 
daily. To any change in the daytime 
dose, there was a corresponding change in 
the number of tablets given as a single dose 
at night and vice versa. Dothiepin was 
supplied as 25 mg tablets, and placebo as 
identical looking tablets. Tablets for day-
time use were dispensed in white bottles 
and for use at night in amber coloured 
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bottles, so as to avoid confusion. 
Response to treatment was evaluated 
using the Hamilton rating scale before 
treatment, daily in the first week and 
thereafter at the end of the second, third 
and fourth weeks of treatment. The 
patients were considered to have marked 
improvement when the iinal score was 
between 1 and 10, moderate improvement 
when it was between 11 and 20, slight 
improvement when it was between 21 and 
30, no change when between 31 and pre-
treatment score, and worse when it ex-
ceeded the pretreatment score. Side-effects 
observed were recorded at each interview. 
RESULT 
Of the 30 patients who were enrolled 
in the study, two discontinued treatment. 
In the remaining 28 patients, there were 
no significant differences in age, sex, num-
ber of attacks of depression, pretreatment 
Hamilton scores and the number of patients 
who received previous treatment, with res-
pect to their assigned treatment group 
(Table 1). 
TABLE 1—Profile of patients 
Group D 
(Thrice 
daily 
dose) 
Group N 
(Single 
nocturnal 
dose) 
No. of patients 
Ses—Male 
Female 
Age—Range 
Mean 
No. of attacks of depression 
—Range .. 
—Mea-i 
Mean pretreatment 
Hamilton 
Score±S. E. 
No. of patients who re-
ceived previous therapy 
14 
6 
8 
22-62 yrs. 
40.2 yrs. 
1—5 
1.9 
35.6 
±3.85 
8 
14 
4 
10 
36-59 yrs. 
46.1 yrs. 
1—10 
2.4 
37.1 
±5.34. 
8 
Efficacy of both the dosage regimens : 
A significant reduction in mean 
Hamilton rating scores was seen in the 
first week of treatment in both the groups 
compared to their mean pretreatment scores 
indicating quick onset of action of dothiepin 
hydrochloride (p<.01). Further gradual 
reduction in mean Hamilton rating scores 
was seen up to the fourth week in both 
the groups. However, maximum reduc-
tion was seen in the first week of treatment 
which is significantly more than the reduc-
tion in scores during subsequent weeks of 
treatment. 
Comparison of efficacy of both the dosage 
regimens : An analysis of variance for 
Hamilton rating score was carried out to 
compare the efficacy of both the dosage 
regimens (Table 2). No significant differ-
ence was observed between the groups in 
terms of reduction in mean Hamilton scores, 
indicating that the single nocturnal treat-
ment schedule is as effective as the thrice 
daily dosage regimen. No significant inter-
action between weeks and groups was 
seen, indicating that the pattern of reduc-
tion in the mean Hamilton scores is similar 
to both the groups. The efficacy and pattern 
TABLE 2—Analysis of variance (variate—weekly 
reduction in score) 
Sum Mean 
Source d.f. of square F 
squares 
Weeks 
Groups 
Patients (within 
groups) 
Weeks x Groups 
Error 
Total 
3 
1 
26 
3 
78 
111 
870.5 
3.6 
1233.6 
89.2 
4203.8 
6400.7 
290.2 
3.6 
47.4 
29.7 
53.9 
5.384 
0.066 
0.88 
0.552 
• 
NS 
NS 
NS 
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of reduction in the mean Hamilton scores 
was similar with the single nocturnal dosage 
schedule and thrice daily dosage schedule. 
Sex difference in response to the two dosage 
regimens : Further analysis was carried out 
to find out sex differences in response to 
both the dosage regimens. 
The average reduction in scores by the 
first week was —12.9 with the day time 
dosage schedule compared to —6.3 with 
the single nocturnal dosage schedule in the 
female group. The male group showed an 
average reduction of —6.7 with the day 
time dosage schedule compared to —14.0 
with the single nocturnal dosage schedule 
(Table 3). It was seen that in the first 
TABLE 3—Sex differences in response to the 
two dosage regimens 
Average change in score 
Female  Male 
N  D  N  D 
No. of patients 
Week First week 
Fourth week 
10 8 4 6 
-6.3 —12.9 —14.0 —6.7 
-16.4 —20.0 —21.0 —18.0 
N=Single nocturnal dose D=Thrice daily dose. 
week of treatment, the female group res-
ponded better with the day time dosage 
schedule while the male group responded 
better with the single nocturnal dosage 
schedule. This difference, however, did 
not reach a level of statistical significance 
(Table 4). The male and female groups 
also did not differ in the final responses 
to both the dosage regimens (Table 5). 
Comparison between responses of individual 
symptoms to both dosage regimens : Favourable 
response (more than 50% reduction in pre-
treatment scores) of individual symptoms 
was analysed to see the differences between 
both the dosage regimens (Table 6). It is 
seen that both the dosage schedules on the 
whole were equally effective. 
TABLE 4—Analysis of variance (variate—lst 
week score—pretreatment score) 
Source 
Group 
Sex 
Sex X Group 
Error 
Total 
DF 
1 
1 
1 
. 24 
. 27 
Sum 
of 
squares 
19.7 
0.9 
301.5 
1920.3 
2242.4 
Mean 
square 
19.7 
0.9 
301.5 
80.0 
F 
0.25 
0.01 
3.77 
NS 
NS 
NS 
NS=Nct significant (p>0.05). 
TABLE 5—Analysis of variance (variate—Ath 
week score—pretreatment score) 
Source 
Group 
Sex 
Sex x Group 
Error 
Total 
DF 
1 
1 
1 
. 24 
. 27 
Sum 
of 
squares 
11.3 
9.3 
67.9 
4860.4 
4948.9 
Mean 
square 
11.3 
9.3 
67.9 
202.5 
F 
0.06 NS 
0.05 NS 
0.33 NS 
NS=Not significant (p>0.05). 
TABLE 6—Response (50% reduction in pre-
treatment score) of various symptoms 
Thrice daily dose Single nocturnal 
dose 
Symptoms • — 
Total Res- Total Res-
ponded ponded 
Depression .. 14 10 (71.4%) 14 10 (71.4%) 
Anxiety .. 14 9 (64.3%) 14 6 (42.9%) 
Insomnia .. 14 9 (64.3%) 14 7 (50 %) 
Clinician's overall assessment : Table 7 
presents the results of the clinician's overall 
assessment which indicates that although 
both the dosage schedules were effective in 
improving the majority of patients, no sig-
nificant difference was observed when both 
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TABLE 7—Clinician's overall assessment 
Mcde- Slight No 
Marked rate Im- Change 
Im- Im- prove- Worse 
prove- prove- ment 
ment ment 
Group D 
(Day treat-
ment) ..5 4 4 1 0 
Group N 
(Night treat-
ment) .. 5 3 2 1 3 
Side-effects .• The nature of side-effects 
observed is summarised in Table 8. Side-
effects reported were mild and did not 
necessitate discontinuation of treatment. 
TABLE 8—Side-effects 
Group D Group N 
(Day (Night) 
treat- treat-
ment) ment) 
A No. of patients, who had side 
effects .. .. 6 g 
B. Symptoms : 
Dryness of mouth .. 3 2 
Constipation .. .. 2 3 
Lack of appetite ., 1 % 
Giddiness on standing .. 2 4 
Drowsiness and sleep .. 0 2 
Burning sensation .. 1 0 
Vomitting .. .. 0 1 
DISCUSSION 
Onset of action of antidepressants is 
of great importance, particularly in severe 
cases where risk of suicide is high. With 
dothiepin hydrochloride, maximum reduc-
tion in mean prctrcatment scores was seen 
in the first week of treatment in both the 
groups compared to reduction seen in sub-
sequent three w.-.eks. Overall response to 
dothiepin hydrochloiidr in both the groups 
was good, taking into consideration that all 
the patients had severe depression. 
The once-a-day dosage schedule has 
the advantage that it is more likely to be 
taken than divided doses (General Prac-
titioner Research Group, 1970 ; Porter, 
1969), particularly since depressed patients 
seldom keep to prescribed drug schedules 
(Wilcox et al., 1965). A similar study 
carried out by Pearcc and Rees (1974) 
showed that more favourable results were 
achieved with patients taking the single 
nocturnal dose which was well tolerated 
in addition to being effective in relieving the 
symptoms of depression. However, we have 
observed that both the dosage regimens 
are equally effective in relieving symptoms 
in patients with depression. In the first 
week of treatment, female patients res-
ponded better (i.e. more reduction in mean 
Hamilton score) to thrice daily dosage 
regimen and male patients responded better 
to single nocturnal dosage regimen com-
pared to thrice daily dosage schedule. By 
the fourth week of treatment, this sex 
difference in response to both the dosage 
regiments disappeared. Side-effects were 
mild with both the dosage regimens and 
the incidence was the same. 
Since the clinical response was similar 
in both dosage regimens, we feel that 
patient compliance would be better with 
single nocturnal administration of the total 
daily dose of dothiepin. 
REFERENCES 
DIMASCIO, A. AND SHADER, R. I. (1969). Drug 
Administration Schedules. Am. J. Psychiat., 
126, 796. 
GENERAL PRACTITIONER RESEARCH GROUP. (1970). 
Dosage schedules in general practice. Prac-
titioner, 204, 719. 
HERRIDGE, C. F. (1975). A retrospective assessment 
of the long-term effects of dothiepin. Int. Phar-
macopsychiat., 10, 208. 
HORESOVSKY, O., FRANC, Z. AND KRAOSE, P. (1967). 
The metabolic fate of a new psychotropic drug 
11- (3 dimethyl-amiuo propylidence) 6, 11 
dihydrodibenz (6,e)- thiopine (Prothiaden). Bio-
chem. Pharmacol., 16, 2421. 
KRAMER, J. C. (1962). Single daily dose schedules 
of imipramine. Comp. Psychiat., 3, 191. COMPARISON OF DIVIDED AND SINGLE DOSE REGIME OF DOTHIEPIN 359 
LIPSEDGE, M. S., REES, W. L. AND PIKE, D.J. (1971). 
A double-blind comparison of dothiepin and 
amitriptyline for the treatment of depression 
with anxiety. Psychopharmacologia, 19, 153. 
MARSHALL, B. (1971). The treatment of depression 
in general practice by a single dcse schedule. 
Practitioner, 206, 806. 
PEARCE, J. B. AND REES, W. L. (1974). A double-
blind comparison of three times daily and single 
night dosage of the tricyclic antidepressant 
dothiepin. J. Int. Med. Res., 24, 12. 
PORTER, A. M. W. (1969). Drug defaulting in a 
general practice. Brit. Med. J., 1, 218. 
SIM, M., REID, D., PALLETT, J. AND GORDON, E. (1975). 
The Hamilton rating scale : An assessment based 
on a dothiepin (Prothiaden) versus imipramine 
(Tofranil) clinical trial. Int. Pharmacopsy-
chiat., 10, 142. 
WILCOX, D. R. C, GILLIAN, R. AND HARE, E. H. 
(1965). Do Psychiatric out-patients take their 
drugs ? Brit. Med. J., 2, 7S0. 